Catalyst OrthoScience Announces Appointment of Todd Wilson, PhD, as Vice President of Medical Education and Training


May 18, 2022

NAPLES, Florida–(BUSINESS WIRE)–OrthoScience Catalysta medical device company focused on the upper limb orthopedics market, is pleased to announce that Dr. Todd Wilson has joined Catalyst as Vice President of Medical Education and Training effective immediately.

“We are thrilled to have an executive with Todd’s experience join our team at Catalyst OrthoScience,” said Catalyst OrthoScience CEO and President Carl O’Connell. “As we continue to grow and establish our presence as an emerging global leader in shoulder pathology solutions, Todd’s leadership, experience and passion for education will help make this vision a reality. reality.”

“I am thrilled to join the Catalyst team at such a pivotal time in the company’s history and contribute to the vision of disrupting traditional approaches to shoulder replacement surgery by delivering innovative treatment solutions. based on the AO principles that make orthopedic surgery less invasive and more efficient for surgeons to deliver superior patient outcomes,” said Dr. Todd Wilson. “My driving force is to exceed expectations by creating a world-class medical education and training program with the creation of the Catalyst Center of Excellence to serve as a foundation for growth and transformation.”

Todd brings over two decades of experience delivering highly innovative, world-class training and development programs that have transformed and positioned medical device and higher education organizations to support significant growth in his leadership roles with Capella University, Xtant Medical, Wright Medical, NuVasive, Orthofix, and more recently, Paragon 28.

Todd received a Ph.D. in Global Leadership from the Indiana Institute of Technology and holds an MBA from Indiana Wesleyan University, which includes bachelor’s degrees in Human Biology and Exercise Science from Indiana University. .

About Catalyst OrthoScience Inc.

Catalyst OrthoScience disrupts the usual approaches to shoulder replacement surgery. The Archer™ CSR Total Shoulder System is unique in providing precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue. The Archer™ R1 Reverse Shoulder System is a single-plateau arthroplasty system that offers surgeon-targeted implant placement, a streamlined and versatile system, and bone-sparing implants. Catalyst OrthoScience’s goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for surgeons and patients.

The company has a growing portfolio of patents and patents pending on its distinctive surgical offerings. Based in Naples, Florida, Catalyst products are available throughout the United States. For more information, visit

Carl O’Connell
CEO and President
OrthoScience Catalyst

Source link


Comments are closed.